Statement Of Financial Position [Abstract]

Mithra Pharmaceuticals S.A. - Filing #3183196

Concept	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	38,354,000 EUR	—	—	—	—	29,921,000 EUR	—	—	—	—	—	—	—	—	—
Right-of-use assets	69,322,000 EUR	—	—	—	—	69,572,000 EUR	—	—	—	—	—	—	—	—	—
Goodwill	5 233 EUR	—	—	—	—	5 233 EUR	—	—	—	—	—	—	—	—	—
Intangible assets other than goodwill	104,954,000 EUR	—	—	—	—	89 005 EUR	—	—	—	—	—	—	—	—	—
Deferred tax assets	63,456,000 EUR	—	—	—	—	50,905,000 EUR	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	32,872,000 EUR	—	—	—	—	138,675,000 EUR	—	—	—	—	—	—	49,720,000 EUR	—	—
Assets	421 918 EUR	—	—	—	—	521 985 EUR	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	32,250,000 EUR	—	—	—	—	31,271,000 EUR	—	—	—	—	—	—	—	—	—
Retained earnings	336 633 EUR	—	—	—	—	219 759 EUR	—	—	—	—	—	—	—	—	—
Other reserves	2 545 EUR	—	—	—	—	13,690,000 EUR	—	—	—	—	—	—	—	—	—
Equity	33 840 EUR	336 634 EUR	2 545 EUR	340 769 EUR	32 250 EUR	157 737 EUR	31 271 EUR	219 759 EUR	332 535 EUR	13 690 EUR	127 673 EUR	3 423 EUR	163 298 EUR	258 898 EUR	28 649 EUR
Liabilities [abstract]
Deferred tax liabilities	6 089 EUR	—	—	—	—	4 363 EUR	—	—	—	—	—	—	—	—	—
Equity and liabilities	421 918 EUR	—	—	—	—	521 985 EUR	—	—	—	—	—	—	—	—	—